ANI Pharmaceuticals Inc — Balance Sheet (NASDAQ:ANIP) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B Total liabilities 265.49 M412.86 M421.55 M446.82 M855.17 M899.65 M Total equity 195.7 M333.89 M313.69 M432.75 M403.68 M540.72 M Total liabilities & shareholders' equities 461.19 M771.6 M760.09 M904.42 M1.28 B1.44 B Total debt —————— Net debt ——————

新闻

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

ANI制药2025年第四季度业绩:罕见病转型推动营收增长44%

ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth

ANI PharmaceuticalsQ4每股收益及营收超出预期

ANI Pharma earnings beat by $0.36, revenue topped estimates

ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)

Brightspring Health Services, BASF, Swiss Re and more set to report Friday

Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up

ANI Pharmaceuticals set to report earnings as Cortrophin drives shift